ABSTRACT
Introduction
Around the world, many patients with end-stage lung diseases are included on the waiting lists for lung transplantation as their best chance of treatment 1 . It is know that the adequate donors for lung transplantation is scarce and this shortage of suitable organs is the key factor for high mortality rates on these waiting lists 2 . One of major initiatives to improve organ usage was the development of ex vivo lung perfusion (EVLP) by Steen et al. 17 that could be used not only to test the organs, but also recover some of the initially rejected lungs for the transplant.
The EVLP system originally described by Steen et al. 17 consists of a transparent rectangular box to support the lung block (with inlets for connecting the cardiopulmonary bypass circuit tubes), a centrifugal pump, a heat exchanger, and a membrane oxygenator, as well as a pressure transducer, a flow meter, and a thermometer. They used as perfusate 1,500 mL of Steen Solution mixed with a variable amount of packed red blood cells, in order to reach a hematocrit level of approximately 15%. A gas mixture (of nitrogen, oxygen, and carbon dioxide) is used to "deoxygenate" the perfusate through the gas exchange membrane, gas flow being adjusted so that the gas concentration in the perfusate is similar to that in the venous blood 4 .
The Toronto group implanted some modifications like the rounded box, the modified cannula for the atrium drainage and probably the most important modification, the use of the Steen solution without the red blood cells, in other words, they recommend a cellular perfusate 5 .
However, the necessity to import the was kept open, and the perfusate was drained from the chamber to the reservoir of the circuit. A digital thermometer inserted at the pulmonary veins took temperature. The membrane oxygenator was connected to a gas mixer that received a CO2/NO2 blend (CO2 -7% and NO2 -93%) and oxygen. So lung oxygenation could be tested, the mixer was set to deoxygenate the solution before going in the pulmonary artery, as it was venous blood. The pH was adjusted using tromethamol to be similar to physiological.
After ventilation was started, the membrane oxygen was turned off. This way, all the oxygen registered analyses is from the lung ventilation. Figure 1 .
Reperfusion has been started with a 100mL/min inflow at 25°C and gradually the lungs were warmed up and the inflow was increased up to 40% of the cardiac output, but keeping pulmonary artery pressure below 20mmHg as shown in Table 1 .
The lung tissue samples were fixed in 10% buffered formalin for 24 hours, embedded in paraffin, sectioned in 5-mm thickness and stained with hematoxylin and eosin. We perform semiquantitative scoring with experienced lung pathologist using histology parameters already described 7 . The severity of these findings was determined using a 4-grade scale: absent=0; minimal=1; moderate=2; and intense=3. The sum of each parameter resulted in the Lung Injury Score (LIS), with a value of 0 to 66.
We assessed apoptosis with the TUNEL method, using After a 60-minute perfusion, a fluid sample from the pulmonary artery and from the pulmonary vein was taken for gases analyses. The perfusion was stopped, new biopsy was made and the lungs were weighted. The left lung was used to assess the formation of pulmonary edema using the wet/dry ratio method. By this method, we can measure how much water there is and assess the edema. So, left lung was weighed after EVLP and maintained in an incubator at 60°C for 24 hours (to dehydrate) and weighed again to calculate the wet/dry weight ratio. We conceived this study as non-inferiority, the required sample size based on previously published experimental studies involving the comparison of lung preservation solutions in experimental models of lung transplantation in dogs and pigs would be too large. In this case, the sample size was determined based on the goal of achieving sufficient power (type II error, No difference was found on weight variation between the groups at the three times studied: a) before ischemic time: 
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Acta Cirúrgica Brasileira -Vol. 30 (5) These previous studies demonstrated that, after reconditioning with Steen Solution, mean PaO 2 reach levels between 380 and 500, similar to our study, even when the national reconditioning solution was used. Even the greater time in mechanical ventilation noticed in our study about five to seven days, was not significant, our the PaO 2 after reconditioning was greater than the reached by
Wierup et al. 4 and Egan et al. 14 , where donors stood, in average, on mechanical ventilation for two days.
One important benefit from the EVLP with the Steen solution is the lung swelling reduction due to the solution's high osmolarity, set by albumin and dextran levels. Furthermore, dextran has antithrombotic proprieties and coats the endothelial surface of the pulmonary circulation and the tubes of the circuit.
In fact, the pulmonary edema is typically present in the process of ischemia-reperfusion factor due to increased vascular permeability and breakage of alveolo-capillary barrier. The more or less water retention in the lung tissue is directly related to graft dysfunction or viability, reflected in the quality of preservation 15 .
In the present study, the domestic manufactured reconditioning solution was less efficient in preventing the formation of edema in the lungs, measured by the ratio of the wet weight (after a 60 minutes perfusion) and dry weight. However, this event does not seem to have done significant loss to the gas exchange, since, as discussed above, oxygenation capacity (measured by PaO 2 ) was good in all reconditioned lungs, regardless of the type of solution used. Furthermore, the weight of the lung blocks recorded in three times throughout the experiment -straight after capture, after 10 hours of cold ischemia, and after 60 minutes of reconditioning -did not change significantly.
We decide to study the hemodynamic behavior on EVLP since it could be an important marker of lung function.
Cypel et al. 16 Histological changes of lung tissue are well characterized in the ischemia-reperfusion process and provide important information on the degree of tissue injury 21 . Considering the semi quantitative evaluation method that we used, the lung injury in the studied lungs was low (four points on average in a 39 points maximum scale) and remained stable throughout the experiment, which was consistent with the physiological parameter both the Steen Solution group and for the APS group.
Cold ischemia may also trigger some series of events that promote the activation of inflammatory mediators 22 , cellular edema 9 and cell death induction, either as necrosis, or apoptosis, both associated with impaired pulmonary function after reperfusion 23, 24 .
Two studies have found that apoptosis is time dependent, increasing after 30, 60 and 120 minutes after the transplant (17%, 22% and 35%, respectively). However, there was no change in the number of apoptotic cells during cold ischemia for 1 to 5 hours or during the preimplantation warm ischemia. Moreover, a positive relationship between the type of cell death and graft function was established 19, 25 . Our results are in accordance with these studies, since the number of apoptotic cells was small and there was no significant difference among times or groups studied.
Conclusion
The alternate perfusate solution was similar to the Steen Solution in all evaluated parameters, except for a higher edema formation.
